Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Pollyea

Showing results (31-40 of 179) with videos related to

Pageof 18
Sort By:
American Journal of Hematology|October 29, 2009
When yellow jackets attack: recurrent and severe anaphylactic reactions to insect bites and stingsDaniel A Pollyea, Tracy I George, Christopher Corless, et al.
Blood Advances|December 24, 2019
Venetoclax for AML: changing the treatment paradigmDaniel A Pollyea, Maria Amaya, Paolo Strati, et al.
Journal of Leukocyte Biology|April 16, 2018
Monocyte function in patients with myelodysplastic syndromeDaniel A Pollyea, Brenna R Hedin, Brian P O'Connor, et al.
Advances in Experimental Medicine and Biology|November 28, 2014
The effects of alcohol and aldehyde dehydrogenases on disorders of hematopoiesisClay Smith, Maura Gasparetto, Craig Jordan, et al.
American Journal of Hematology|July 17, 2024
Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go?Jennifer Marvin-Peek, Jason S Gilbert, Daniel A Pollyea, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2019
Response Kinetics and Clinical Benefits of Nonintensive AML Therapies in the Absence of Morphologic ResponseEytan M Stein, Courtney D DiNardo, Daniel A Pollyea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2021
Optimizing Risk Stratification in Acute Myeloid Leukemia: Dynamic Models for a Dynamic Therapeutic LandscapeNicholas J Short, Martin S Tallman, Daniel A Pollyea, et al.
Haematologica|August 2, 2014
Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trialsDaniel A Pollyea, Jonathan A Gutman, Lia Gore, et al.
Annals of the New York Academy of Sciences|March 20, 2014
Aldehyde dehydrogenases in acute myeloid leukemiaClay Smith, Maura Gasparetto, Keith Humphries, et al.
Acta Haematologica|April 8, 2025
Recombinant Myeloid Hematopoietic Growth Factors and Clinical Stimulation of Acute Myeloid Leukemia Cells: A Narrative ReviewJason S Gilbert, Daniel A Pollyea, Thomas J Walsh, et al.
Pageof 18

Showing results (31-40 of 179) with videos related to

Sort By:
Pageof 18
American Journal of Hematology|October 29, 2009
When yellow jackets attack: recurrent and severe anaphylactic reactions to insect bites and stingsDaniel A Pollyea, Tracy I George, Christopher Corless, et al.
Blood Advances|December 24, 2019
Venetoclax for AML: changing the treatment paradigmDaniel A Pollyea, Maria Amaya, Paolo Strati, et al.
Journal of Leukocyte Biology|April 16, 2018
Monocyte function in patients with myelodysplastic syndromeDaniel A Pollyea, Brenna R Hedin, Brian P O'Connor, et al.
Advances in Experimental Medicine and Biology|November 28, 2014
The effects of alcohol and aldehyde dehydrogenases on disorders of hematopoiesisClay Smith, Maura Gasparetto, Craig Jordan, et al.
American Journal of Hematology|July 17, 2024
Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go?Jennifer Marvin-Peek, Jason S Gilbert, Daniel A Pollyea, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2019
Response Kinetics and Clinical Benefits of Nonintensive AML Therapies in the Absence of Morphologic ResponseEytan M Stein, Courtney D DiNardo, Daniel A Pollyea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2021
Optimizing Risk Stratification in Acute Myeloid Leukemia: Dynamic Models for a Dynamic Therapeutic LandscapeNicholas J Short, Martin S Tallman, Daniel A Pollyea, et al.
Haematologica|August 2, 2014
Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trialsDaniel A Pollyea, Jonathan A Gutman, Lia Gore, et al.
Annals of the New York Academy of Sciences|March 20, 2014
Aldehyde dehydrogenases in acute myeloid leukemiaClay Smith, Maura Gasparetto, Keith Humphries, et al.
Acta Haematologica|April 8, 2025
Recombinant Myeloid Hematopoietic Growth Factors and Clinical Stimulation of Acute Myeloid Leukemia Cells: A Narrative ReviewJason S Gilbert, Daniel A Pollyea, Thomas J Walsh, et al.
Pageof 18